{"id":212098,"name":"GENENTECH USA, INC.","slug":"genentech-usa-inc","state":"CA","country":"United States of America","description":"Biotechnology company.","totalSpending":270000,"filings":7,"yearlySpending":[{"year":2021,"income":70000},{"year":2022,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["DLA PIPER LLP (US)"],"lobbyists":["ALEX PINSON","JAMIE GREGORIAN","JAMES GREENWOOD"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)"],"sampleDescriptions":["Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit re","Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit re","Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit re","Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval reimbursement, and pricing; patient assistance and access programs; and benefit redesign. H.","Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions reg"]}